Changes to the tax code revised the way R&D Expenses are treated at tax time. Congress created the policy that is now diverting dollars away from essential R&D. Congress can fix this. You can help them understand why they need to. Continue reading
Category Archives: Advocacy and Regulations
Bill for Funding the Arizona Health Innovation Trust Fund Passes Senate Appropriations
SB1019: appropriation; health innovation trust fund received its first hearing in Arizona’s Senate Health and Human Services Committee on January 16, 2024 and passed with unanimous support. On January 30, 2024, the bill received a do pass recommendation from Senate Appropriation with a vote of 7 ayes, 2 nays and 1 not voting
As currently written, SB1019 appropriates $5M to the Arizona Health Innovation Trust Fund, and declares that it is the Legislature’s intent that the Fund, consisting of monies appropriated by the Legislature, gifts or grants donated or given to the Fund and earnings from the Fund, steadily grow to ultimately maintain a permanent endowment balance of at least $200 million. SB1019 is now is eligible for consideration by the Senate Rules Committee.Continue reading
How Every Arizonan Can Help Shape Public Policy
Did you know that the Arizona Legislature has a system that makes it possible for the people of Arizona to provide feedback on proposed policy as it moves through the process? It is called the Request to Speak System (RTS) and your voice matters.Continue reading
Bill Proposing an Appropriation into the Arizona Health Innovation Trust Fund Receives Unanimous Support in the Senate Health and Human Services Committee
SB1019: appropriation; health innovation trust fund received its first hearing in Arizona’s Senate Health and Human Services Committee on January 16, 2024. As currently written, SB1019 appropriates $5M to the Arizona Health Innovation Trust Fund, and declares that it is the Legislature’s intent that the Fund, consisting of monies appropriated by the Legislature, gifts or grants donated or given to the Fund and earnings from the Fund, steadily grow to ultimately maintain a permanent endowment balance of at least $200 million.
SB1019 received a unanimous do pass recommendation. It now is eligible for consideration by the Senate Appropriations Committee.Continue reading
An Interview with AZBio President and CEO on Life Sciences M&A in Arizona
Recently, PULSE had a conversation with Joan Koerber-Walker, president and CEO of AZBio, which recently celebrated 20 years of supporting the growth of Arizona’s life science industry. Joan, who has led AZBio since 2011, has a vested interest in making Arizona a place where bioscience organizations can thrive and find success, while supporting economic growth at the local and state level. PULSE asked Joan for her perspective on how mergers and acquisitions (M&A) have impacted and benefited Arizona’s economic outlook and contributions to the state.
In Comments to FDA, AdvaMed Maintains Support of Agency’s Authority to Regulate LDTs
WASHINGTON, D.C. – Today, AdvaMedDx submitted comments in response to the Food and Drug Administration’s Proposed Rule: Medical Devices; Laboratory Developed Tests. AdvaMedDx is a division of AdvaMed representing companies that develop in vitro diagnostic (IVD) tests.
AHCCCS Requests Federal Authority To Expand Eligibility for KidsCare
Nearly 10,000 More Children Could Become Eligible for CoverageContinue reading
New Report Explores Latest Best Practices in State Bioscience Economic Development Initiatives
Today, the Biotechnology Innovation Organization (BIO), in partnership with the Council of State Bioscience Associations (CSBA), released a new report on the best practices in state bioscience economic development measures, “The U.S. Biosciences Industry in the States: Best Practices in Innovation, Partnerships, and Job Creation.”Continue reading
BIO-backed bills that would support startups passed by House
Two bills to create a healthy investment environment for biotech startups passed the House late May 30 with overwhelming bipartisan support. The legislation was also supported by the Biotechnology Innovation Organization (BIO).
Continue reading